Hönig J F, Merten H A, Korth O, Halling F, Köstering H
Zentrum Zahn-, Mund- und Kieferheilkunde der Universität Göttingen.
Dtsch Z Mund Kiefer Gesichtschir. 1991 Sep-Oct;15(5):330-3.
Antithrombin III and protein C are the major inhibitors of the plasma clotting system. Since adequate thromboembolism protection requires a cofactor AT III for heparin to provide full antithrombotic coverage, the preoperative AT III and protein C levels in the plasma of 105 patients treated with marcumar are measured. The understanding of the physiological role of these inhibitors of the plasma clotting system and of the causes for their decrease should directly lead to the indications for laboratory analysis.
抗凝血酶III和蛋白C是血浆凝血系统的主要抑制剂。由于充分的血栓栓塞保护需要抗凝血酶III作为辅助因子以使肝素提供完全的抗血栓形成作用,因此对105例接受香豆素治疗的患者血浆中的术前抗凝血酶III和蛋白C水平进行了测定。了解这些血浆凝血系统抑制剂的生理作用及其降低的原因应能直接得出实验室分析的指征。